|
|
Volumn 20, Issue SUPPL. 1, 2001, Pages
|
|
Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization
a
|
|
Author keywords
Heat labile toxin; Immunization; Intranasal; Vaccines
|
|
Indexed keywords
IMMUNOGLOBULIN A ANTIBODY;
IMMUNOGLOBULIN G ANTIBODY;
INFLUENZA VACCINE;
TRIPLE VACCINE;
ANTIBODY TITER;
ARTICLE;
CLINICAL IMMUNOLOGY;
DIAGNOSTIC TEST;
DIAGNOSTIC VALUE;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG SAFETY;
ESCHERICHIA COLI;
HEMAGGLUTINATION;
HUMAN;
IMMUNIZATION;
IMMUNOGENICITY;
INFECTION PREVENTION;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS;
NONHUMAN;
NOSE MUCOSA;
PRIORITY JOURNAL;
RESPIRATORY SYSTEM;
SALIVA;
VACCINATION;
VIRUS INHIBITION;
VIRUS REPLICATION;
VIRUS RESISTANCE;
VIRUS STRAIN;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRANASAL;
ANIMALS;
BACTERIAL TOXINS;
ENTEROTOXINS;
ESCHERICHIA COLI PROTEINS;
FERRETS;
HUMANS;
VACCINES;
|
|
EID: 0035888201
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(01)00292-4 Document Type: Article |
|
Times cited : (59)
|
|
References (5)
|
